Wasabi

Condiciones de salud que Wasabi puede ayudar a apoyar.

• HipocondríaCientífico

  Wasabi isothiocyanates, particularly 6-MSITC, are potent activators of the Nrf2/Keap1-ARE antioxidant response pathway, inducing a suite of cytoprotective enzymes including HO-1, ALDH2, glutathione S-transferase, and other phase II detoxification enzymes. This has been confirmed in hepatocyte, neuronal, and in vivo models. 6-MSITC is structurally analogous to sulforaphane, one of the best-characterized dietary Nrf2 inducers.

• EccemaCientífico

  Wasabi's 6-MSITC potently suppresses COX-2, iNOS, and pro-inflammatory cytokines that drive arthritic joint inflammation, and blocks NF-κB signaling. In the rat metabolic syndrome model, wasabi attenuated acute inflammation in the heart tissue. These anti-inflammatory mechanisms are directly applicable to articular inflammation, and wasabi has traditional use for joint pain in Japanese medicine.

• HipoglucemiaCientífico

  Wasabi isothiocyanates—both 6-MSITC and allyl isothiocyanate—have demonstrated antiplatelet activity in vitro against human platelets, inhibiting aggregation induced by multiple agonists including collagen, ADP, arachidonic acid, and thrombin. 6-MSITC also reduces tissue factor expression in human endothelial cells. This activity is well-characterized mechanistically, though no clinical trials in humans have assessed thrombotic outcomes.

• HipotensiónCientífico

  Wasabi supplementation reduced systolic blood pressure in diet-induced hypertensive rats. Wasabi leaf extract has also been shown to reduce blood pressure in animal studies. The antihypertensive mechanism may involve Nrf2/HO-1 pathway activation and anti-inflammatory effects on vascular endothelium. No human clinical trials have specifically evaluated wasabi's effect on blood pressure.

• Fatiga SuprarrenalCientífico

  In diabetic rodent models, wasabi-derived allyl isothiocyanate reduced blood glucose and increased glucose transporter-2 expression and insulin receptor substrate-1, while activating Nrf2 and downregulating NF-κB in liver and kidney. A separate study found wasabi powder preserved renal function in type 2 diabetic mice. Human clinical evidence for glycemic effects is absent; evidence is preclinical.

• Manchas de la edadCientífico

  Wasabi leafstalk contains p-hydroxycinnamic acid (HCA), an osteogenic factor identified in preclinical research that stimulates osteoblastic bone formation and suppresses osteoclastic bone resorption in vitro. Oral administration of HCA restored bone loss in ovariectomized and diabetic animal models. Wasabi leafstalk extract also suppressed osteoclast-like cell formation stimulated by parathyroid hormone.

• Válvula IleocecalCientífico

  In rat models, wasabi supplementation decreased total plasma cholesterol in both normal-diet and high-fat diet animals. Allyl isothiocyanate from wasabi also reduced total cholesterol in diabetic rodents. The mechanism likely involves AMPK activation and PPARγ/PPARα modulation affecting lipid metabolism. Human evidence is absent.

• Virus de Epstein BarrCientífico

  An open-label clinical trial of ME/CFS patients found that 9.6 mg/day of 6-MSITC for 12 weeks significantly improved performance status and reduced subjective symptoms including pain and cognitive dysfunction. A separate single-arm trial in healthy adults with daily fatigue reported improvements in pre-task fatigue, sleep, and mood. Both studies lacked placebo controls, limiting causal inference.

• ApendicitisCientífico

  6-MSITC from wasabi potently suppresses key inflammatory mediators including COX-2, iNOS, IL-6, and TNF-α, and blocks NF-κB and AP-1 signaling pathways in multiple in vitro and animal models. These anti-inflammatory mechanisms have been well-characterized at the molecular level. While direct human RCT data on inflammatory biomarkers are limited, the mechanistic evidence is robust.

• IncontinenciaCientífico

  A double-blind RCT in healthy adults 60+ showed 12 weeks of 6-MSITC supplementation significantly improved episodic memory. Preclinical research shows 6-MSITC protects dopaminergic neurons and reduces neuroinflammation, offering relevance to Alzheimer's and Parkinson's prevention. Nrf2 pathway activation in neurons underpins the neuroprotective mechanism.

• Bultos en el SenoCientífico

  6-MSITC from wasabi inhibited production of IL-6 and CXCL10 in TNF-α-stimulated human oral epithelial cells, suppressing inflammatory signaling pathways (STAT3, NF-κB, p70S6K). Additionally, wasabi isothiocyanates have demonstrated antimicrobial activity relevant to oral pathogens and dental plaque bacteria. In Japan, wasabi has a documented traditional role as an antimicrobial food preservative.

• BronquitisCientífico

  Wasabi/6-MSITC targets multiple aging-relevant biological processes: Nrf2-mediated antioxidant defense, neuroinflammation reduction, episodic memory improvement in older adults (RCT), bone-protective effects, and cardiovascular risk factor modulation. A human RCT specifically enrolled adults aged 60+ and demonstrated memory benefits. The compound is described in research as a candidate for healthy aging and prevention of age-related diseases.

• Moretones (prevención)Científico

  Wasabi extract reduced body weight gain in high-carbohydrate, high-fat diet-fed rats, and wasabi leaf extract inhibited adipose hypertrophy by suppressing PPARγ and stimulating AMPK. The anti-obesity effect of 6-MSITC is mediated through lipid metabolism regulation via PPAR and AMPK pathways. All evidence is preclinical; no human RCTs on body weight have been conducted.

• JuanetesCientífico

  Wasabi's 6-MSITC demonstrates anti-atherosclerotic activity via endothelial Nrf2/HO-1 activation, antiplatelet effects, and reduction of cardiac inflammatory markers in animal models. In a rat metabolic syndrome model, wasabi attenuated acute inflammation in the heart and reduced lipid deposition in the liver. These effects collectively support a cardioprotective profile, though human trial data are lacking.

• Envenenamiento QuímicoCientífico

  Wasabi isothiocyanates are potent inducers of hepatic Phase II detoxification enzymes—including glutathione S-transferase and HO-1—via Nrf2/Keap1-ARE pathway activation, a mechanism well-established in liver cell models. Wasabi's long-chain ITCs are reported to be substantially more potent than standard isothiocyanates (such as those in broccoli) at inducing Phase II enzymes. Animal data also show wasabi protects against liver fat deposition in metabolic syndrome models.

• EscalofríosCientífico

  A 2023 double-blind RCT found that 12 weeks of 6-MSITC supplementation (the key wasabi isothiocyanate) significantly improved episodic memory—including verbal memory and face-name association—in healthy adults aged 60+. This builds on earlier evidence from ME/CFS patient studies showing reduced brain fog and improved cognitive processing speed. The proposed mechanism involves Nrf2-mediated antioxidant protection and reduction of neuroinflammation.

• GingivitisCientífico

  In a rat model of diet-induced metabolic syndrome, wasabi supplementation reduced body weight, blood pressure, plasma cholesterol, triglycerides, and cardiac inflammation simultaneously. 6-MSITC's pleiotropic effects on PPAR, AMPK, NF-κB, and Nrf2 pathways address multiple components of metabolic syndrome. It is listed as a candidate treatment for metabolic syndrome in a 2024 PMC systematic review, though human evidence is absent.

• Conmociones cerebralesCientífico

  Wasabi isothiocyanates, including allyl isothiocyanate, exhibit broad-spectrum antibacterial activity against food-borne and oral pathogens. Isothiocyanates are reported to inhibit microbial adhesion and proliferation, reducing dental plaque bacteria. Wasabi has been used traditionally in Japan as an antimicrobial food pairing, underpinning its potential to modulate the oral microbiome.

• Infección (bacteriana)Científico

  Wasabi leafstalk-derived p-hydroxycinnamic acid (HCA) stimulates osteoblast activity and inhibits osteoclast formation, and in animal models reversed bone loss from ovariectomy and diabetic states. These findings support wasabi's potential role in osteoporosis prevention via dual osteogenic and anti-resorptive mechanisms. Evidence is entirely preclinical.

• Enfermedad de CrohnCientífico

  In an open-label study of 20 healthy adults with daily fatigue, 4.8 mg/day of 6-MSITC for 4 weeks improved self-reported sleep quality compared to baseline. In the ME/CFS trial, a trend toward improved PSQI scores was observed (1 vs. 3 patients meeting normal sleep threshold after treatment), though formal significance was not reached. Evidence is early-stage due to open-label designs.

• DebilidadCientífico

  Wasabi leaf extract reduced plasma triglycerides in animal studies, and in the diet-induced metabolic syndrome rat model, wasabi supplementation significantly decreased plasma triglycerides in high-fat diet animals. In diabetic rodents, allyl isothiocyanate also reduced triglyceride concentrations. No human clinical evidence for triglyceride reduction exists.

Sistemas corporales que Wasabi puede ayudar a apoyar.

• No hay sistemas corporales disponibles.